3.0 T MRI IVIM-DWI for predicting the efficacy of neoadjuvant chemoradiation for locally advanced rectal cancer

Author:

Hu Hongbo,Jiang Huijie,Wang Song,Jiang Hao,Zhao Sheng,Pan Wenbin

Abstract

Abstract Purpose The purpose of this study was to determine the diagnostic performance of intravoxel incoherent motion (IVIM) on assessing response to neoadjuvant chemoradiation (nCRT) in patients with Locally Advanced Rectal Cancer (LARC). Methods 50 patients with rectal cancer who underwent magnetic resonance (MR) imaging before and after nCRT, the values of pre-nCRT and post-nCRT IVIM-DWI parameters apparent diffusion coefficient (ADC), diffusion coefficient (D), false diffusion coefficient (D*), and perfusion fraction (f), together with the percentage changes (∆% parametric value) induced by nCRT were calculated. According to the patient's response to nCRT, the patients were divided into pathological complete response (pCR) and non-pCR groups, Good Response (GR) group and Poor Response (PR) group, and the above values were compared between different groups. Univariate and multiple logistic regression analysis were done to investigate the relation between different parameters and patient nCRT. Draw ROC curve according to sensitivity and specificity, and compare its diagnostic efficacy. Results There were no significant differences in the baseline data of 50 patients. After nCRT, the ADC and D values for LARC increased significantly (all p < 0.05). The pCR group (n = 9) had higher preD*, pref, postD*, ∆%ADC and ∆%D values than the non-pCR group (n = 41) (all p < 0.05). The GR group (n = 17) exhibited higher post D, ∆%ADC and ∆%D values than the PR group (n = 33) (all p < 0.05). From the results of Logistic regression analysis found that ∆%ADC and ∆%D were significantly correlated with patients' response to nCRT. Based on ROC analysis, ∆%D had a higher area under the curve value than ∆%ADC (p = 0.009) in discriminating the pCR from non-pCR groups. Conclusions IVIM-DWI technology may be helpful in identifying the pCR and GR patients to nCRT for LARC.

Funder

The National Key Research and Development Program of China

National Natural Science Foundation of China

Scientific Research Transformation Special Fund of Heilongjiang Academy of Medical Sciences

Natural Science Foundation of Shanghai

Publisher

Springer Science and Business Media LLC

Subject

Urology,Gastroenterology,Radiology Nuclear Medicine and imaging,Radiological and Ultrasound Technology

Reference32 articles.

1. Pak JN, Jung JH, Park JE, Hwang J, Lee HJ, Shim BS, Kim SH (2020) p53 dependent LGR5 inhibition and caspase 3 activation are critically involved in apoptotic effect of compound K and its combination therapy potential in HCT116 cells. Phytother Res. https://doi.org/10.1002/ptr.6717

2. MacLeod C, Wilson P, Watson A (2020) Colon capsule endoscopy: an innovative method for detecting colorectal pathology during the Covid-19 pandemic? Colorectal Dis. https://doi.org/10.1111/codi.15134

3. Erika C, De Mattia E, Dreussi E, Montico M, Palazzari E, Navarria F, Bergamo F, Belluco C, Quartuccio L, De Vita S, Canzonieri V, Gagno S, Zanusso C, Buonadonna A, Pucciarelli S, De Paoli A, Toffoli G (2020) Immunogenetic markers in IL17F predict the risk of metastases spread and overall survival in rectal cancer patients treated with neoadjuvant chemoradiotherapy. Radiother Oncol. https://doi.org/10.1016/j.radonc.2020.04.055

4. M DIT, Rosa C, Caravatta L, Augurio A, Borzillo V, S DIS, Perrotti F, Taraborrelli M, Cianci R, Innocenti P, P DIS, Colasante A, Angelucci D, Basti M, Sindici G, Mazzola L, Pizzicannella G, N DIB, Marchioni M, M DIN, Genovesi D (2020) Treatment Intensification for Locally Advanced Rectal Cancer: Impact on Pathological Complete Response and Outcomes. In Vivo 34 (3):1223-1233. https://doi.org/10.21873/invivo.11896

5. Liang HQ, Dong ZY, Liu ZJ, Luo J, Zeng Q, Liao PY, Wu DH (2019) Efficacy and safety of consolidation chemotherapy during the resting period in patients with local advanced rectal cancer. Oncol Lett 17 (2):1655-1663. https://doi.org/10.3892/ol.2018.9804

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3